BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu L, Yang C, Ma J, Zhang X, Wang Q, Xiong X. NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice. Hum Exp Toxicol 2021;40:S666-75. [PMID: 34752167 DOI: 10.1177/09603271211052991] [Reference Citation Analysis]
2 Wegrzyniak O, Rosestedt M, Eriksson O. Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:7348. [PMID: 34298967 DOI: 10.3390/ijms22147348] [Reference Citation Analysis]
3 Xia F, Zhu P, Chen XP, Zhang BX, Zhang MY. Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis. J Oncol 2022;2022:7531452. [PMID: 35342424 DOI: 10.1155/2022/7531452] [Reference Citation Analysis]
4 Song Y, Feng Y, Sun LH, Zhang BJ, Yao HJ, Qiao JG, Zhang SF, Zhang P, Liu B. Role of argon plasma coagulation in treatment of esophageal varices. World J Clin Cases 2021; 9(3): 521-527 [PMID: 33553390 DOI: 10.12998/wjcc.v9.i3.521] [Reference Citation Analysis]
5 Voutilainen SH, Kosola SK, Lohi J, Jahnukainen T, Pakarinen MP, Jalanko H. Expression of fibrosis-related genes in liver allografts: Association with histology and long-term outcome after pediatric liver transplantation. Clin Transplant 2021;:e14373. [PMID: 34043847 DOI: 10.1111/ctr.14373] [Reference Citation Analysis]
6 Liu XY, Li D, Li TY, Wu Y, Piao JS, Piao MG. Vitamin A - modified Betulin polymer micelles with hepatic targeting capability for hepatic fibrosis protection. European Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ejps.2022.106189] [Reference Citation Analysis]
7 Zheng WV, Li Y, Cheng X, Xu Y, Zhou T, Li D, Xiong Y, Wang S, Chen Z. Uridine alleviates carbon tetrachloride-induced liver fibrosis by regulating the activity of liver-related cells. J Cell Mol Med 2021. [PMID: 34970843 DOI: 10.1111/jcmm.17131] [Reference Citation Analysis]
8 Paolini C, Agarbati S, Benfaremo D, Mozzicafreddo M, Svegliati S, Moroncini G. PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis. Int J Mol Sci 2022;23:3904. [PMID: 35409263 DOI: 10.3390/ijms23073904] [Reference Citation Analysis]
9 Liu T, Chen S, Xie X, Liu H, Wang Y, Qi S, Shi L, Zhou X, Zhang J, Wang S, Wang Y, Chen S, Dou S, Jiang X, Cui R, Jiang H. Soluble TREM-1, as a new ligand for the membrane receptor Robo2, promotes hepatic stellate cells activation and liver fibrosis. J Cell Mol Med 2021. [PMID: 34750987 DOI: 10.1111/jcmm.17033] [Reference Citation Analysis]
10 Nie X, Yu Q, Li L, Yi M, Wu B, Huang Y, Zhang Y, Han H, Yuan X. Kinsenoside Protects Against Radiation-Induced Liver Fibrosis via Downregulating Connective Tissue Growth Factor Through TGF-β1 Signaling. Front Pharmacol 2022;13:808576. [DOI: 10.3389/fphar.2022.808576] [Reference Citation Analysis]
11 Kim JY, Choi Y, Leem J, Song JE. Heme Oxygenase-1 Induction by Cobalt Protoporphyrin Ameliorates Cholestatic Liver Disease in a Xenobiotic-Induced Murine Model. Int J Mol Sci 2021;22:8253. [PMID: 34361019 DOI: 10.3390/ijms22158253] [Reference Citation Analysis]
12 Flamini S, Sergeev P, Viana de Barros Z, Mello T, Biagioli M, Paglialunga M, Fiorucci C, Prikazchikova T, Pagano S, Gagliardi A, Riccardi C, Zatsepin T, Migliorati G, Bereshchenko O, Bruscoli S. Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment. Cell Death Dis 2021;12:421. [PMID: 33927191 DOI: 10.1038/s41419-021-03704-w] [Reference Citation Analysis]
13 Yan Y, Zeng J, Xing L, Li C. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation. Biomedicines 2021;9:1014. [PMID: 34440218 DOI: 10.3390/biomedicines9081014] [Reference Citation Analysis]
14 Yuan S, Dong M, Zhang H, Jiang X, Yan C, Ye R, Zhou H, Chen L, Lian H, Jin W. Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGFβR1. Int J Biol Macromol 2022;194:556-62. [PMID: 34822828 DOI: 10.1016/j.ijbiomac.2021.11.098] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li S, Wang C, Zhang X, Su W. Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis. Front Physiol 2021;12:688259. [PMID: 34135776 DOI: 10.3389/fphys.2021.688259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pinheiro D, Dias I, Freire T, Thole AA, Stumbo AC, Cortez EAC, de Carvalho L, de Carvalho SN. Effects of mesenchymal stem cells conditioned medium treatment in mice with cholestatic liver fibrosis. Life Sci 2021;281:119768. [PMID: 34186042 DOI: 10.1016/j.lfs.2021.119768] [Reference Citation Analysis]
17 Kalra K, Eberhard J, Farbehi N, Chong JJ, Xaymardan M. Role of PDGF-A/B Ligands in Cardiac Repair After Myocardial Infarction. Front Cell Dev Biol 2021;9:669188. [PMID: 34513823 DOI: 10.3389/fcell.2021.669188] [Reference Citation Analysis]
18 Zhou X, Liang Z, Qin S, Ruan X, Jiang H. Serum-derived miR-574-5p-containing exosomes contribute to liver fibrosis by activating hepatic stellate cells. Mol Biol Rep 2021. [PMID: 34843038 DOI: 10.1007/s11033-021-07008-2] [Reference Citation Analysis]
19 Nishi M, Matsumoto T, Fujisawa K, Suehiro Y, Takami T, Yamamoto N, Yamasaki T, Sakaida I. Mesenchymal Stem Cells Induce a Fibrolytic Phenotype By Regulating mmu-miR-6769b-5p Expression in Macrophages. Stem Cells Dev 2020;29:1457-66. [PMID: 32962510 DOI: 10.1089/scd.2020.0123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Li B, Liu J, Xin X, Zhang L, Zhou J, Xia C, Zhu W, Yu H. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int J Med Sci 2021;18:615-25. [PMID: 33437196 DOI: 10.7150/ijms.51589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ezhilarasan D. Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases. Hepatobiliary Pancreat Dis Int 2021;20:315-22. [PMID: 33975780 DOI: 10.1016/j.hbpd.2021.04.010] [Reference Citation Analysis]
22 Zou L, Jiang J, Zhang H, Zhong W, Xiao M, Xin S, Wang Y, Xing W. Comparing and combining MRE, T1ρ, SWI, IVIM, and DCE-MRI for the staging of liver fibrosis in rabbits: Assessment of a predictive model based on multiparametric MRI. Magn Reson Med 2021. [PMID: 34931716 DOI: 10.1002/mrm.29126] [Reference Citation Analysis]
23 Cheng J, Chen Z, Zuo G, Cao W. Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. J Int Med Res 2022;50:3000605221074525. [PMID: 35086375 DOI: 10.1177/03000605221074525] [Reference Citation Analysis]
24 Ge S, Yang W, Chen H, Yuan Q, Liu S, Zhao Y, Zhang J. MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs. Int J Mol Sci 2021;22:12413. [PMID: 34830293 DOI: 10.3390/ijms222212413] [Reference Citation Analysis]
25 Ge C, Tan J, Lou D, Zhu L, Zhong Z, Dai X, Sun Y, Kuang Q, Zhao J, Wang L, Liu J, Wang B, Xu M. Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling. Redox Biology 2022;51:102274. [DOI: 10.1016/j.redox.2022.102274] [Reference Citation Analysis]
26 Yue H, Li Y, Cai W, Bai X, Dong P, Wang J. Antarctic krill peptide alleviates liver fibrosis via downregulating the secondary bile acid mediated NLRP3 signaling pathway. Food Funct 2022. [PMID: 35762853 DOI: 10.1039/d1fo04241f] [Reference Citation Analysis]
27 Chiabotto G, Pasquino C, Camussi G, Bruno S. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis. Front Cell Dev Biol 2020;8:594794. [PMID: 33425900 DOI: 10.3389/fcell.2020.594794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Reungoat E, Grigorov B, Zoulim F, Pécheur EI. Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis. Cancers (Basel) 2021;13:2270. [PMID: 34065048 DOI: 10.3390/cancers13092270] [Reference Citation Analysis]
29 Li N, Shan S, Li XQ, Chen TT, Qi M, Zhang SN, Wang ZY, Zhang LL, Wei W, Sun WY. G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases. Front Immunol 2021;12:822345. [PMID: 35111168 DOI: 10.3389/fimmu.2021.822345] [Reference Citation Analysis]
30 Huisman TM, Dieterich DT, Friedman SL. Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update. J Exp Pharmacol 2021;13:329-38. [PMID: 33776490 DOI: 10.2147/JEP.S265286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Gong Y, Yang Y. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review. Life Sci 2020;256:117909. [PMID: 32512009 DOI: 10.1016/j.lfs.2020.117909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
32 Shu G, Dai C, Yusuf A, Sun H, Deng X. Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate cell activation in vitro and CCl4-induced liver fibrosis in mice via upregulating Smad7 and subsequent suppression of TGF-β/Smad cascade. J Nutr Biochem 2022;:109039. [PMID: 35533902 DOI: 10.1016/j.jnutbio.2022.109039] [Reference Citation Analysis]
33 Shan L, Wang F, Zhai D, Meng X, Liu J, Lv X. New Drugs for Hepatic Fibrosis. Front Pharmacol 2022;13:874408. [DOI: 10.3389/fphar.2022.874408] [Reference Citation Analysis]
34 Stone RC, Chen V, Burgess J, Pannu S, Tomic-Canic M. Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response. Int J Mol Sci 2020;21:E8590. [PMID: 33202590 DOI: 10.3390/ijms21228590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Wei A, Zhao F, Hao A, Liu B, Liu Z. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m6A/Ptch1 axis through Hedgehog pathway. Gene 2021;813:146125. [PMID: 34921949 DOI: 10.1016/j.gene.2021.146125] [Reference Citation Analysis]
36 Vilfranc CL, Che LX, Patra KC, Niu L, Olowokure O, Wang J, Shah SA, Du CY. BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis. World J Hepatol 2021; 13(3): 343-361 [PMID: 33815677 DOI: 10.4254/wjh.v13.i3.343] [Reference Citation Analysis]
37 Boulahtouf Z, Virzì A, Baumert TF, Verrier ER, Lupberger J. Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences. Int J Mol Sci 2022;23:2787. [PMID: 35269929 DOI: 10.3390/ijms23052787] [Reference Citation Analysis]
38 Chiabotto G, Ceccotti E, Tapparo M, Camussi G, Bruno S. Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype. Front Cell Dev Biol 2021;9:777462. [PMID: 34796180 DOI: 10.3389/fcell.2021.777462] [Reference Citation Analysis]
39 San‐miguel B, Fernández‐palanca P, Mauriz JL, Tuñón MJ, González‐gallego J. Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence. Journal Cellular Physiology. [DOI: 10.1002/jcp.30735] [Reference Citation Analysis]
40 Cao X, Liang Y, Liu R, Zao X, Zhang J, Chen G, Liu R, Chen H, He Y, Zhang J, Ye Y. Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy. Front Pharmacol 2022;13:793888. [PMID: 35330838 DOI: 10.3389/fphar.2022.793888] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Shin MR, Lee JA, Kim M, Lee S, Oh M, Moon J, Nam JW, Choi H, Mun YJ, Roh SS. Gardeniae Fructus Attenuates Thioacetamide-Induced Liver Fibrosis in Mice via Both AMPK/SIRT1/NF-κB Pathway and Nrf2 Signaling. Antioxidants (Basel) 2021;10:1837. [PMID: 34829709 DOI: 10.3390/antiox10111837] [Reference Citation Analysis]
42 Wang ZY, Keogh A, Waldt A, Cuttat R, Neri M, Zhu S, Schuierer S, Ruchti A, Crochemore C, Knehr J, Bastien J, Ksiazek I, Sánchez-Taltavull D, Ge H, Wu J, Roma G, Helliwell SB, Stroka D, Nigsch F. Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis. Sci Rep 2021;11:19396. [PMID: 34588551 DOI: 10.1038/s41598-021-98806-y] [Reference Citation Analysis]
43 Virzì A, Gonzalez-Motos V, Tripon S, Baumert TF, Lupberger J. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. J Clin Med 2021;10:977. [PMID: 33801181 DOI: 10.3390/jcm10050977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
44 Zhang Y, Zeng W, Xia Y. TWEAK/Fn14 axis is an important player in fibrosis. J Cell Physiol 2021;236:3304-16. [PMID: 33000480 DOI: 10.1002/jcp.30089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Yu S, Ericson M, Fanjul A, Erion DM, Paraskevopoulou M, Smith EN, Cole B, Feaver R, Holub C, Gavva N, Horman SR, Huang J. Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells. ACS Chem Biol 2022;17:918-29. [PMID: 35274923 DOI: 10.1021/acschembio.2c00006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Li S, Gan L, Tian YJ, Tian Y, Fan RZ, Huang D, Yuan FY, Zhang X, Lin Y, Zhu QF, Tang GH, Yan XL, Yin S. Presegetane diterpenoids from Euphorbia sieboldiana as a new type of anti-liver fibrosis agents that inhibit TGF-β/Smad signaling pathway. Bioorg Chem 2021;114:105222. [PMID: 34375196 DOI: 10.1016/j.bioorg.2021.105222] [Reference Citation Analysis]
47 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
48 Saadat N, Puttabyatappa M, Elangovan VR, Dou J, Ciarelli JN, Thompson RC, Bakulski KM, Padmanabhan V. Developmental Programming: Prenatal Testosterone Excess on Liver and Muscle Coding and Noncoding RNA in Female Sheep. Endocrinology 2022;163:bqab225. [PMID: 34718504 DOI: 10.1210/endocr/bqab225] [Reference Citation Analysis]
49 Wang Z, Yang X, Gui S, Yang F, Cao Z, Cheng R, Xia X, Li C. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Front Pharmacol 2021;12:779606. [PMID: 34899344 DOI: 10.3389/fphar.2021.779606] [Reference Citation Analysis]
50 Li Y, Dong J, Zhou Y, Ye X, Cai Z, Zhang X, Shen L, Zhang M, Zhang W, Cai J. Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats. Biochem Biophys Res Commun 2021;584:87-94. [PMID: 34775285 DOI: 10.1016/j.bbrc.2021.10.078] [Reference Citation Analysis]
51 Tang Y, Wu P, Li L, Xu W, Jiang J. Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases. Front Immunol 2022;13:880523. [DOI: 10.3389/fimmu.2022.880523] [Reference Citation Analysis]
52 Li YJ, Liu RP, Ding MN, Zheng Q, Wu JZ, Xue XY, Gu YQ, Ma BN, Cai YJ, Li S, Lin S, Zhang LY, Li X. Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles. Acta Pharmacol Sin 2022. [PMID: 35027662 DOI: 10.1038/s41401-021-00843-w] [Reference Citation Analysis]
53 Wu J, Xie F, Ji H, Zhang Y, Luo Y, Xia L, Lu T, He K, Sha M, Zheng Z, Yong J, Li X, Zhao D, Yang Y, Xia Q, Xue F. A Clinical-Radiomic Model for Predicting Indocyanine Green Retention Rate at 15 Min in Patients With Hepatocellular Carcinoma. Front Surg 2022;9:857838. [DOI: 10.3389/fsurg.2022.857838] [Reference Citation Analysis]
54 Leilei L, Xue S, Yan L, Yuyuan L, Ying W, Wenke Q, Xuesong Y, Ming L. PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-β1. Biochem Biophys Res Commun 2021;569:125-31. [PMID: 34243068 DOI: 10.1016/j.bbrc.2021.07.002] [Reference Citation Analysis]
55 Wang C, Ma C, Fu K, Liu Y, Gong L, Peng C, Li Y. Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism. J Ethnopharmacol 2022;296:115478. [PMID: 35716920 DOI: 10.1016/j.jep.2022.115478] [Reference Citation Analysis]
56 Weiskirchen R. Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis". Cells 2020;9:E1105. [PMID: 32365575 DOI: 10.3390/cells9051105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Binatti E, Gerussi A, Barisani D, Invernizzi P. The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities. Int J Mol Sci 2022;23:6649. [PMID: 35743092 DOI: 10.3390/ijms23126649] [Reference Citation Analysis]
58 Maruyama H, Shiina S. Collaterals in portal hypertension: anatomy and clinical relevance. Quant Imaging Med Surg 2021;11:3867-81. [PMID: 34341755 DOI: 10.21037/qims-20-1328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 El-Gendy ZA, El-Marasy SA, Ahmed RF, El-Batran SA, Abd El-Rahman SS, Ramadan A, Youssef SAH. Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats. Heliyon 2021;7:e07159. [PMID: 34159266 DOI: 10.1016/j.heliyon.2021.e07159] [Reference Citation Analysis]
60 Wu MC, Meng QH. Current understanding of mesenchymal stem cells in liver diseases. World J Stem Cells 2021; 13(9): 1349-1359 [PMID: 34630867 DOI: 10.4252/wjsc.v13.i9.1349] [Reference Citation Analysis]
61 Pinto C, Ninfole E, Benedetti A, Marzioni M, Maroni L. Involvement of Autophagy in Ageing and Chronic Cholestatic Diseases. Cells 2021;10:2772. [PMID: 34685751 DOI: 10.3390/cells10102772] [Reference Citation Analysis]
62 Tsujita Y, Sofue K, Ueshima E, Ueno Y, Hori M, Murakami T. Clinical Application of Quantitative MR Imaging in Nonalcoholic Fatty Liver Disease. Magn Reson Med Sci 2022. [PMID: 35584952 DOI: 10.2463/mrms.rev.2021-0152] [Reference Citation Analysis]
63 Zhao Y, Li H. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease. Scand J Gastroenterol 2022;:1-6. [PMID: 35189786 DOI: 10.1080/00365521.2022.2041085] [Reference Citation Analysis]
64 Ni M, Wang L, Yu H, Wen X, Yang Y, Liu G, Hu Y, Li Z. Radiomics Approaches for Predicting Liver Fibrosis With Nonenhanced T1 -Weighted Imaging: Comparison of Different Radiomics Models. J Magn Reson Imaging 2021;53:1080-9. [PMID: 33043991 DOI: 10.1002/jmri.27391] [Reference Citation Analysis]
65 Eom JA, Kwon GH, Kim NY, Park EJ, Won SM, Jeong JJ, Raja G, Gupta H, Asmelash Gebru Y, Sharma S, Choi YR, Kim HS, Yoon SJ, Hyun JY, Jeong MK, Park HJ, Min BH, Choi MR, Kim DJ, Suk KT. Diet-Regulating Microbiota and Host Immune System in Liver Disease. Int J Mol Sci 2021;22:6326. [PMID: 34199182 DOI: 10.3390/ijms22126326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Azuma YT, Fujita T, Izawa T, Hirota K, Nishiyama K, Ikegami A, Aoyama T, Ike M, Ushikai Y, Kuwamura M, Fujii H, Tsuneyama K. IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism. Cells 2021;10:3513. [PMID: 34944021 DOI: 10.3390/cells10123513] [Reference Citation Analysis]
67 Lurje I, Hammerich L, Tacke F. Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer. Int J Mol Sci 2020;21:E7378. [PMID: 33036244 DOI: 10.3390/ijms21197378] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
68 Chen R, Lv C, Zhao X, Ma D, Lai D, Zhao Y, Zhang L, Tou J. Expression and possible role of Smad3 in postnecrotizing enterocolitis stricture. World Jnl Ped Surgery 2022;5:e000289. [DOI: 10.1136/wjps-2021-000289] [Reference Citation Analysis]
69 Hsiao Y, Cao Y, Yue Y, Zhou J. Relationship between Axial Length and Levels of TGF-β in the Aqueous Humor and Plasma of Myopic Patients. Biomed Res Int 2021;2021:8863637. [PMID: 33728344 DOI: 10.1155/2021/8863637] [Reference Citation Analysis]
70 Han X, Wang J, Gu H, Liao X, Jiang M. Predictive value of liver cirrhosis using metabolite biomarkers of bile acid in the blood: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28529. [PMID: 35089190 DOI: 10.1097/MD.0000000000028529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Tang J, Xiong K, Zhang T, Han Han. Application of Metabolomics in Diagnosis and Treatment of Chronic Liver Diseases. Crit Rev Anal Chem 2020;:1-11. [PMID: 33146026 DOI: 10.1080/10408347.2020.1842172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Magri MC, Alvarez MSM, Iogi AA, Alves GM, Manchiero C, Dantas BP, Prata TVG, Nunes AKDS, Tengan FM. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C. Pathog Dis 2021;79:ftab007. [PMID: 33476381 DOI: 10.1093/femspd/ftab007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev 2021;174:127-39. [PMID: 33857552 DOI: 10.1016/j.addr.2021.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Gong J, Gong H, Liu Y, Tao X, Zhang H. Calcipotriol attenuates liver fibrosis through the inhibition of vitamin D receptor-mediated NF-κB signaling pathway. Bioengineered 2022;13:2658-72. [DOI: 10.1080/21655979.2021.2024385] [Reference Citation Analysis]
75 Rezq S, Hassan R, Mahmoud MF. Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways. Int Immunopharmacol 2021;100:108140. [PMID: 34536742 DOI: 10.1016/j.intimp.2021.108140] [Reference Citation Analysis]
76 Segura-Azuara NLÁ, Varela-Chinchilla CD, Trinidad-Calderón PA. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Front Med (Lausanne) 2021;8:774079. [PMID: 35096868 DOI: 10.3389/fmed.2021.774079] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Shi T, Morishita A, Kobara H, Masaki T. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci 2021;22:10630. [PMID: 34638971 DOI: 10.3390/ijms221910630] [Reference Citation Analysis]
78 Tan Z, Sun H, Xue T, Gan C, Liu H, Xie Y, Yao Y, Ye T. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Front Cell Dev Biol 2021;9:730176. [PMID: 34621747 DOI: 10.3389/fcell.2021.730176] [Reference Citation Analysis]
79 Hayakawa S, Ohishi T, Miyoshi N, Oishi Y, Nakamura Y, Isemura M. Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid. Molecules 2020;25:E4553. [PMID: 33027981 DOI: 10.3390/molecules25194553] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
80 Kotlyarov S, Bulgakov A. Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. Cells 2021;10:2978. [PMID: 34831201 DOI: 10.3390/cells10112978] [Reference Citation Analysis]
81 Xia J, Jin G, Hua Q, Cui S, Li J. Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study. Front Endocrinol 2022;13:917304. [DOI: 10.3389/fendo.2022.917304] [Reference Citation Analysis]
82 Yang Y, Sun M, Li W, Liu C, Jiang Z, Gu P, Li J, Wang W, You R, Ba Q, Li X, Wang H. Rebalancing TGF-β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis. Clin Transl Med 2021;11:e410. [PMID: 34323416 DOI: 10.1002/ctm2.410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
83 Jain D, Chaudhary P, Varshney N, Bin Razzak KS, Verma D, Khan Zahra TR, Janmeda P, Sharifi-Rad J, Daştan SD, Mahmud S, Docea AO, Calina D. Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis. J Oncol 2021;2021:5905357. [PMID: 34925509 DOI: 10.1155/2021/5905357] [Reference Citation Analysis]
84 Shen DF, Cheng H, Cai BZ, Cai WF, Wang B, Zhu Q, Wu YB, Liu M, Chen RJ, Gao FF, Zhang YM, Niu YD, Shi GG. N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice. Acta Pharmacol Sin 2022;43:133-45. [PMID: 33758354 DOI: 10.1038/s41401-021-00630-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 An L, Zhang M, Lin Y, Jiang T, Xu K, Xiao S, Cai L, Kwan HY, Liu Z, Su T. Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expression. Phytomedicine 2022;103:154199. [DOI: 10.1016/j.phymed.2022.154199] [Reference Citation Analysis]
86 Cai Q, Gan C, Tang C, Wu H, Gao J. Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease. Front Pharmacol 2021;12:784591. [PMID: 34887768 DOI: 10.3389/fphar.2021.784591] [Reference Citation Analysis]
87 Ogawa H, Kaji K, Nishimura N, Takagi H, Ishida K, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H. Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis. J Cell Mol Med 2021;25:4001-13. [PMID: 33609067 DOI: 10.1111/jcmm.16363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Wu YY, Wu S, Li XF, Luo S, Wang A, Yin SQ, Huang C, Li J. LncRNA MEG3 reverses CCl4-induced liver fibrosis by targeting NLRC5. Eur J Pharmacol 2021;911:174462. [PMID: 34536366 DOI: 10.1016/j.ejphar.2021.174462] [Reference Citation Analysis]
89 Li Z, Wang Z, Dong F, Shi W, Dai W, Zhao J, Li Q, Fang ZE, Ren L, Liu T, Wei Z, Mou W, Lin L, Yang Y, Xiao X, Ma L, Bai Z. Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways. Front Pharmacol 2021;12:745561. [PMID: 34675811 DOI: 10.3389/fphar.2021.745561] [Reference Citation Analysis]
90 Santhakumar C, Gane EJ, Liu K, Mccaughan GW. Current perspectives on the tumor microenvironment in hepatocellular carcinoma. Hepatol Int 2020;14:947-57. [DOI: 10.1007/s12072-020-10104-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
91 Wang Y, Huang B, Jin T, Ocansey DKW, Jiang J, Mao F. Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy. Front Immunol 2022;13:835005. [DOI: 10.3389/fimmu.2022.835005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Niu X, Meng Y, Wang Y, Li G. Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro. Molecules 2022;27:3738. [PMID: 35744862 DOI: 10.3390/molecules27123738] [Reference Citation Analysis]
93 Raj D, Sharma V, Upadhyaya A, Kumar N, Joshi R, Acharya V, Kumar D, Patial V. Swertia purpurascens Wall ethanolic extract mitigates hepatic fibrosis and restores hepatic hepcidin levels via inhibition of TGFβ/SMAD/NFκB signaling in rats. J Ethnopharmacol 2021;284:114741. [PMID: 34699946 DOI: 10.1016/j.jep.2021.114741] [Reference Citation Analysis]
94 Creeden JF, Kipp ZA, Xu M, Flight RM, Moseley HNB, Martinez GJ, Lee WH, Alganem K, Imami AS, McMullen MR, Roychowdhury S, Nawabi AM, Hipp JA, Softic S, Weinman SA, McCullumsmith R, Nagy LE, Hinds TD Jr. Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents. Hepatology 2022. [PMID: 35313030 DOI: 10.1002/hep.32467] [Reference Citation Analysis]
95 Ezhilarasan D. Relaxin in hepatic fibrosis: What is known and where to head? Biochimie 2021;187:144-51. [PMID: 34102254 DOI: 10.1016/j.biochi.2021.06.001] [Reference Citation Analysis]
96 Su SB, Tao L, Liang XL, Chen W. Long noncoding RNA GAS5 inhibits LX-2 cells activation by suppressing NF-κB signalling through regulation of the miR-433-3p/TLR10 axis. Dig Liver Dis 2021:S1590-8658(21)00843-4. [PMID: 34903500 DOI: 10.1016/j.dld.2021.11.002] [Reference Citation Analysis]
97 Herrero A, Knetemann E, Mannaerts I. Review: Challenges of In Vitro CAF Modelling in Liver Cancers. Cancers (Basel) 2021;13:5914. [PMID: 34885024 DOI: 10.3390/cancers13235914] [Reference Citation Analysis]
98 Santo MCCDE, Gryschek RCB, Farias AQ, Andraus W, Carvalho NB, Leite OHM, Castro FC, Cerri GG, Hypólitti GH, Carnevale FC, Assis AM. Management and treatment of decompensated hepatic fibrosis and severe refractory Schistosoma mansoni ascites with transjugular intrahepatic portosystemic shunt. Rev Inst Med Trop Sao Paulo 2022;64:e26. [PMID: 35384957 DOI: 10.1590/S1678-9946202264026] [Reference Citation Analysis]
99 Liang T, He Y, Mo S, Chen Z, Liao X, Zhou X, Yang C, Zhao S, Han C, Zhu G, Su H, Ye X, Peng T. Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100695] [Reference Citation Analysis]
100 Zhu H, Lu Y, Xia J, Liu Y, Chen J, Lee J, Koh K, Chen H. Aptamer-Assisted Protein Orientation on Silver Magnetic Nanoparticles: Application to Sensitive Leukocyte Cell-Derived Chemotaxin 2 Surface Plasmon Resonance Sensors. Anal Chem 2022. [PMID: 35045701 DOI: 10.1021/acs.analchem.1c04448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Catanzaro R, Aleo A, Sciuto M, Zanoli L, Balakrishnan B, Marotta F. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study. Clin Exp Hepatol 2021;7:111-6. [PMID: 34027123 DOI: 10.5114/ceh.2021.104543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Li H. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma. Dig Liver Dis 2021:S1590-8658(21)00375-3. [PMID: 34344577 DOI: 10.1016/j.dld.2021.07.006] [Reference Citation Analysis]
103 Liu RX, Ma SF, Chen YL, Ma LF, Wang JD, Zhan ZJ. Tetrodecadazinone, a novel tetrodecamycin-pyridazinone hybrid with anti-liver fibrosis activity from Streptomyces sp. HU051. Bioorg Chem 2021;119:105573. [PMID: 34952245 DOI: 10.1016/j.bioorg.2021.105573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Yang G, Yang Y, Ma X, Huang L, Li W, Song X, Zhang H, Liu W, Lu J. Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer. Technol Cancer Res Treat 2020;19:1533033820943244. [PMID: 32812509 DOI: 10.1177/1533033820943244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Zhao J, Qi YF, Yu YR. STAT3: A key regulator in liver fibrosis. Ann Hepatol 2021;21:100224. [PMID: 32702499 DOI: 10.1016/j.aohep.2020.06.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
106 Delgado ME, Cárdenas BI, Farran N, Fernandez M. Metabolic Reprogramming of Liver Fibrosis. Cells 2021;10:3604. [PMID: 34944111 DOI: 10.3390/cells10123604] [Reference Citation Analysis]
107 Li J, Wu T, Zhang X, Du Y, Wei B, Wang J. Clinical Application of Liver Diseases Diagnosis using Ultrahigh-sensitive Liquid Chromatography-Mass Spectrometry for Sialic Acids Detection. Journal of Chromatography A 2022. [DOI: 10.1016/j.chroma.2022.462837] [Reference Citation Analysis]
108 Xie Y, Du D, Zhang L, Yang Y, Zou Z, Li Z, Zhou L, Shang R, Zhou P. TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway. Chem Biol Interact 2022;354:109839. [PMID: 35101388 DOI: 10.1016/j.cbi.2022.109839] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Guo M, Akter F, Luo X, Meng X, Jonas B. WITHDRAWN: The cell fate determinant NUMB regulates ferroptosis through interacting with P53/MFRN1 signaling. Redox Biology 2020. [DOI: 10.1016/j.redox.2020.101793] [Reference Citation Analysis]
110 Yan J, Fang X, Feng Y, Cui X, Li F, Luo W, Ma X, Liang J, Feng J. Identification of key genes associated with the progression of liver fibrosis to hepatocellular carcinoma based on iTRAQ proteomics and GEO database. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100681] [Reference Citation Analysis]
111 Yang H, Wang J, Liu ZG. Multi-faceted role of pyroptosis mediated by inflammasome in liver fibrosis. J Cell Mol Med 2022. [PMID: 35415891 DOI: 10.1111/jcmm.17277] [Reference Citation Analysis]
112 Bulboacă AE, Porfire AS, Rus V, Nicula CA, Bulboacă CA, Bolboacă SD. Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity. Antioxidants 2022;11:412. [DOI: 10.3390/antiox11020412] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Luo W, Guo S, Zhou Y, Zhao J, Wang M, Sang L, Chang B, Wang B. Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy. Front Microbiol 2022;13:873160. [PMID: 35572649 DOI: 10.3389/fmicb.2022.873160] [Reference Citation Analysis]
114 Costa CFFA, Sampaio-Maia B, Araujo R, Nascimento DS, Ferreira-Gomes J, Pestana M, Azevedo MJ, Alencastre IS. Gut Microbiome and Organ Fibrosis. Nutrients 2022;14:352. [PMID: 35057530 DOI: 10.3390/nu14020352] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
115 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Wei CT, Wang YW, Wu YC, Lin LW, Chen CC, Chen CY, Kuo SM. Reparative Efficacy of Liposome-Encapsulated Oleanolic Acid against Liver Inflammation Induced by Fine Ambient Particulate Matter and Alcohol in Mice. Pharmaceutics 2022;14:1108. [PMID: 35631694 DOI: 10.3390/pharmaceutics14051108] [Reference Citation Analysis]